Vaccine safety surveillance

OTHER2 trials

Sponsors

GlaxoSmithKline

Conditions

InfluenzaInfluenza, Human

Unknown Phase

Post-authorisation Safety Study (PASS) of Influenza Vaccine in United Kingdom (UK)

CompletedNCT02567721

GlaxoSmithKlineInfluenza

Start: 2015-10-31End: 2015-11-30Updated: 2016-02-12

Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines

CompletedNCT02893878

GlaxoSmithKlineInfluenza, Human

Start: 2016-09-12End: 2016-11-24Updated: 2019-02-11